Thus, researchers conducted studies to distinguish LTBI from active TB by using cytokines specific to the MTB antigens, by using differentially expressed genes with subsequent validation via reverse transcription polymerase chain reaction (RT-PCR), and by using monocyte chemoattractant protein-1 (MCP-1) [8,9,10]. This evidence concerns the gene CCL2 and tuberculosis.